No Picture
Stock News

MAP – Microba Life Sciences

Microba Life Sciences operates in the emerging US$4.89 billion gut microbiome sector impacting the chronic disease management market. The world leading technology developed by Microba is tapping into a growing body of research demonstrating that […]